Maynard Um
-
-
-
-
-
-
-
Maxim Group Downgrades Quince Therapeutics Inc. (QNCX) to Hold
-
-
-
-
-
-
-
Quince Therapeutics (QNCX) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Quince Therapeutics publishes eDSP pharmacokinetic modeling study
-
-
-
-
-
-
-
Quince Therapeutics Inc. (QNCX) PT Lowered to $4 at D. Boral Capital
-
-
-
-
-
-
-
Quince Therapeutics (QNCX) Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial
-
-
-
-
418,486 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

